When looking at the dashboard of a pharmacy at the end of the month and seeing that the net margin has decreased again despite a stable dispensing volume, the problem usually does not come from the revenue. It comes from how one manages the expense items, ancillary missions, and the time spent by the team on non-value-added tasks.
The management of a pharmacy is no longer just about buying and selling medications well: it requires a constant trade-off between profitability, regulatory compliance, and quality of service to the patient.
Electronic invoicing in pharmacies: a technical project not to be underestimated
Since 2024, electronic invoicing is gradually being rolled out for professionals subject to VAT. For pharmacy owners, this means checking the compatibility of the pharmacy management software (LGO) with partner dematerialization platforms and ensuring that supplier flows (wholesalers, laboratories) are properly connected.
This point is often overlooked because the dispensing of reimbursed medications goes through a specific circuit (SESAM-Vitale, teletransmission). The invoices affected by the reform are those related to purchases of parapharmacy products, service provisions, and current expenses. A poorly configured LGO generates duplicates, rejections, or payment delays that weigh on cash flow.
Before embarking on a complete audit, one can start with a specific point: check that each supplier flow is properly connected to the Factur-X format or the format expected by the chosen platform. This is a back-office task that takes a few hours with the LGO editor but avoids weeks of regularization later. Specialized resources for supporting pharmacies exist, such as those offered on https://pharmazenconseil.fr/, which help structure this type of compliance.
Pharmacy profitability: managing the margin through missions, not just through volumes
The reform of the pharmacy economic model pushes pharmacies to reduce their dependence on the volume of boxes dispensed. The stated goal of the authorities is to better value the pharmaceutical intervention itself: vaccination, rapid diagnostic orientation tests (TROD), shared medication reviews, screening.
On the ground, this changes the way profitability is calculated. A pharmacy that achieves a decent revenue from dispensing but does not bill for any additional missions is missing out on an increasing share of income. Public health missions become a lever for autonomous margin, distinct from the traditional prescription flow.
Structuring missions so that they are actually billed
The problem faced by many pharmacy owners is not the absence of missions, but their poor traceability. A pharmaceutical consultation conducted at the counter without an appointment, without a documented protocol, and without entry into the LGO will never be billed to Health Insurance.
For these missions to contribute to the pharmacy’s performance, it is necessary to:
- Define dedicated slots in the team’s schedule, with an identified confidentiality space (even minimal)
- Train each technician on the data entry protocols in the LGO so that traceability is automatic
- Monthly track the number of missions completed and billed, just as one tracks the generic substitution rate
Returns vary from one pharmacy to another depending on the clientele and geographical area, but the principle remains the same: a non-traced mission is a non-paid mission.
Stock management in pharmacies: balancing safety and financial immobilization
Stock often represents the first item of immobilization in a pharmacy. Overstocking low-turnover products ties up cash without generating margin. Conversely, a stockout on a chronic treatment can lead to losing a loyal patient to a neighboring pharmacy.
Optimization involves regular analysis of turnover. Most LGOs offer ABC classification tools (by revenue or by dispensing frequency), but they are rarely consulted outside of the annual inventory.
Implementing monthly tracking of dormant references
A dormant reference is a product that has not moved for several months. In parapharmacy, this is common after a promotional campaign or a change in supplier range. Identifying each month the ten most immobilized references allows for initiating supplier returns, targeted promotions, or delistings before the loss accumulates.
This tracking takes no more than an hour per month if an automatic alert is set up in the LGO. It is a simple management reflex that has a direct impact on available cash flow.
Capital and pharmacy transfer: rules changing in 2026
The legal structures for pharmacy ownership (SEL, SPFPL) are under increased scrutiny. Recent legislative proposals aim to create a national register of participations and to more strictly regulate preference shares in liberal practice companies.
For an owner preparing for a sale or an assistant pharmacist considering a buyout, these developments change the interpretation of financial structures. The structuring of capital must be reviewed with specialized advice before any operation, as the conditions for entering capital may become stricter in the coming months.
In practical terms, this means that a planned transfer project for 2027 must be anticipated now:
- Check the compliance of the existing SEL/SPFPL structure with the new transparency requirements
- Anticipate the impact of a potential register of participations on the valuation of the pharmacy
- Secure financing by considering updated banking criteria for pharmacy buyouts
This is not a topic that can be resolved between two dispensings. The legal and accounting complexity justifies dedicated support, distinct from regular accounting.
Pharmacy management has become a multi-criteria steering exercise where regulatory compliance, mission profitability, and stock control intertwine daily. Owners who structure these three axes in advance, rather than endure them through reforms, preserve both their margin and the quality of their pharmaceutical practice.
